Atlas Trials

A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat

Clinical trial NCT00647829 · COMPLETED

Trial details

NCT number
NCT00647829
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pharyngitis
Start date
2003-02-01
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.